Katharine Herbert

643 total citations
18 papers, 465 citations indexed

About

Katharine Herbert is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Katharine Herbert has authored 18 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Katharine Herbert's work include PARP inhibition in cancer therapy (4 papers), Sirtuins and Resveratrol in Medicine (3 papers) and RNA Interference and Gene Delivery (3 papers). Katharine Herbert is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), Sirtuins and Resveratrol in Medicine (3 papers) and RNA Interference and Gene Delivery (3 papers). Katharine Herbert collaborates with scholars based in United Kingdom, United States and Australia. Katharine Herbert's co-authors include Charlie Foster, Helen Doll, Emma Plugge, Elizabeth T. Snow, Remko Prevo, Geoff S. Higgins, Giacomo Pirovano, Anthony L. Cook, Thomas M. Ashton and Gonzalo Rodríguez‐Berriguete and has published in prestigious journals such as The Lancet, Nature Communications and Genes & Development.

In The Last Decade

Katharine Herbert

18 papers receiving 460 citations

Peers

Katharine Herbert
Yeonhee Park South Korea
Joanne Abbotts United Kingdom
Katie White United States
Lisa C. Vinikoor United States
Amy Cha United States
Karen Maughan United Kingdom
Katharine Herbert
Citations per year, relative to Katharine Herbert Katharine Herbert (= 1×) peers Haiqing Fang

Countries citing papers authored by Katharine Herbert

Since Specialization
Citations

This map shows the geographic impact of Katharine Herbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharine Herbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharine Herbert more than expected).

Fields of papers citing papers by Katharine Herbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharine Herbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharine Herbert. The network helps show where Katharine Herbert may publish in the future.

Co-authorship network of co-authors of Katharine Herbert

This figure shows the co-authorship network connecting the top 25 collaborators of Katharine Herbert. A scholar is included among the top collaborators of Katharine Herbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharine Herbert. Katharine Herbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Herbert, Katharine, Rosanna Upstill‐Goddard, Stephan B. Dreyer, et al.. (2025). Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma. British Journal of Cancer. 133(3). 381–393. 1 indexed citations
2.
Wright, Thomas A., Yuan Yan Sin, Katharine Herbert, et al.. (2024). Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC. Scientific Reports. 14(1). 8998–8998. 1 indexed citations
3.
Freter, Rasmus, Paola Falletta, Omid Omrani, et al.. (2021). Establishment of a fluorescent reporter of RNA-polymerase II activity to identify dormant cells. Nature Communications. 12(1). 3318–3318. 5 indexed citations
4.
Herbert, Katharine, Rathi Puliyadi, Remko Prevo, et al.. (2020). Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress. Cell Death and Differentiation. 28(4). 1333–1346. 16 indexed citations
5.
Puliyadi, Rathi, Remko Prevo, Gonzalo Rodríguez‐Berriguete, et al.. (2020). External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase. Cancers. 12(4). 798–798. 15 indexed citations
6.
Herbert, Katharine, Jean‐Philippe Lambert, Pakavarin Louphrasitthiphol, et al.. (2019). BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma. Genes & Development. 33(5-6). 310–332. 25 indexed citations
7.
Prevo, Remko, Giacomo Pirovano, Rathi Puliyadi, et al.. (2018). CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner. Cell Cycle. 17(12). 1513–1523. 54 indexed citations
8.
Herbert, Katharine, Thomas M. Ashton, Remko Prevo, Giacomo Pirovano, & Geoff S. Higgins. (2018). T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics. Cell Death and Disease. 9(11). 1089–1089. 60 indexed citations
9.
Latz, Amanda O. & Katharine Herbert. (2018). The completion agenda in community colleges: What it is, why it matters, and where it’s going. Community College Journal of Research and Practice. 43(5). 390–391. 9 indexed citations
10.
Herbert, Katharine, et al.. (2018). Transformative Pedagogy with Innovative Methodology: Using Photovoice to Understand Community College Students’ Needs. Community College Journal of Research and Practice. 42(7-8). 536–549. 7 indexed citations
11.
Pirovano, Giacomo, Thomas M. Ashton, Katharine Herbert, et al.. (2017). TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy. British Journal of Cancer. 117(4). 503–512. 22 indexed citations
12.
Glowacki‐Dudka, Michelle, et al.. (2016). How Do Indiana Women of Achievement Awardees Support Preskill and Brookfield’s Learning as a Way of Leading Framework?. Journal of Transformative Education. 14(3). 234–253. 1 indexed citations
13.
Toleman, Michelle S., Katharine Herbert, Noel McCarthy, & David N. Church. (2015). Vaccination of chemotherapy patients—effect of guideline implementation. Supportive Care in Cancer. 24(5). 2317–2321. 16 indexed citations
14.
Herbert, Katharine, Anthony L. Cook, & Elizabeth T. Snow. (2014). SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes. Journal of Dermatological Science. 74(2). 142–149. 11 indexed citations
15.
Herbert, Katharine, Adele F. Holloway, Anthony L. Cook, Paulynn Suyin Chin, & Elizabeth T. Snow. (2014). Arsenic exposure disrupts epigenetic regulation of SIRT1 in human keratinocytes. Toxicology and Applied Pharmacology. 281(1). 136–145. 25 indexed citations
16.
Herbert, Katharine, Anthony L. Cook, & Elizabeth T. Snow. (2014). SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes. Toxicology and Applied Pharmacology. 277(3). 288–297. 18 indexed citations
17.
Herbert, Katharine, Emma Plugge, Charlie Foster, & Helen Doll. (2012). Prevalence of risk factors for non-communicable diseases in prison populations worldwide: a systematic review. The Lancet. 379(9830). 1975–1982. 157 indexed citations
18.
Herbert, Katharine & Elizabeth T. Snow. (2012). Modulation of arsenic-induced epidermal growth factor receptor pathway signalling by resveratrol. Chemico-Biological Interactions. 198(1-3). 38–48. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026